Cohort studycited by the Tayebat archiveabstract only checked A-WHT-13 standard review

Whole grain and bran and diabetes

Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review.

Overview

de Munter JS et al.. PLoS Med 2007 · PMID 17760498 · DOI 10.1371/journal.pmed.0040261

Highest whole grain intake: about 25-37% lower diabetes risk.

Does the study support the specific claim? Partly · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Whole grain and diabetes

How was the study done?

Cohort + meta-analysis

How many people, animals or samples were studied?

286,125

What was actually found?

Inverse association

How large was the observed effect?

21% per 2 servings

What do the results mean in everyday life?

Whole grain helpful

What are the study's limitations?

Observational

What does it say about Elawady's specific claim?

Supports whole grains

Do the results apply to Germany and Europe?

Moderate

What can explicitly not be concluded from this study?

Cause

Scientific in-depth review

1. Full reference

Authors
de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM
Journal
PLoS Med
Year
2007
Identifier
PMID 17760498 DOI 10.1371/journal.pmed.0040261 · PMC1952203
Verification
verified – PubMed E-utilities efetch, 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

COI statement empty in record; NIH grants.

2. Research question

Whole grain, bran, germ and T2D

3. Study design and population

Study design
Cohort study – Cohort (NHS I/II) plus systematic review/meta-analysis
Population

161,737 US women

Country

USA

Period

12-18 y

Sample size

161,737; 6486 cases; pooled 286,125

4. Methods and endpoints

Exposure / intervention

Whole grain, bran, germ

Comparator

Lowest quintile

Endpoints

T2D

Statistical methods

Multivariable; pooled

5. Actual results

Results

Highest vs lowest whole grain: RR 0.63 (0.57-0.69) NHS I, 0.68 (0.57-0.81) NHS II; after BMI 0.75 and 0.86. Bran similar; germ not significant after bran adjustment. Pooled 6 cohorts: +2 servings/day RR reduction 21% (13-28%).

Absolute risks

not reported

Authors' conclusion

Whole grain inversely associated with T2D, stronger for bran.

6. Strengths

  • Large

7. Weaknesses

  • Observational

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns

9. Assessment of the statistical interpretation

Attenuated by BMI.

10. Relevance to the specific claim

Supports C-WHT-04/05.

11. Independent contrary findings

12. Transferability to Germany and Europe

Moderate.

13. Overall methodological judgement

Good evidence for whole grain.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biassome concerns
Precision of resultshigh
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks

Use by the Tayebat archive

Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.

What the archive says about the study

Listed in bibliography only.

D. What does the archive derive from it?

Implicitly: bran removed in milling.

E. Is this derivation scientifically justified?

Supports whole grain/bran benefit, not white-flour harm per se.

Adequacy of the interpretation (by the archive)
not applicable